| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Articles |
From the Departments of Pathology* and
Immunology,
University of Göttingen,
Göttingen, Germany
The anaphylatoxin derived from the fifth component of the human
complement system (C5a) mediates its effects by binding to a single
high-affinity receptor (C5aR/CD88), the expression of which has
been traditionally thought to be restricted to granulocytes,
monocytes, macrophages (M
), and cell lines of
myeloid origin. Recent immunohistochemical data suggested that human
bronchial and alveolar cells express C5aR as well. To reexamine the
tissue distribution of human C5aR expression, transcription of
the C5aR gene was investigated in normal and pathologically affected
human lung (bronchopneumonia, tuberculosis), large
intestine (acute appendicitis, Crohn's disease), and
skin (pyogenic granuloma, lichen planus) using in
situ hybridization. In contrast to previous evidence,
C5aR mRNA could not be detected in pulmonary or intestinal epithelial
cells, whereas keratinocytes in inflamed but not in normal skin
revealed detectable levels of C5aR transcripts. Additionally,
it could be documented that only migrating M
express C5aR
mRNA, whereas sessile M
in normal tissues and
epithelioid/multinucleated M
found in granulomatous lesions do not.
Because C5a has been demonstrated to upregulate the expression of
interleukin (IL)-6 in human monocytes, we also studied IL-6
gene transcription in parallel to the C5aR. IL-6 mRNA was detectable in
many tissue M
. Surprisingly, a tight co-expression of C5aR
and IL-6 mRNA was observed in keratinocytes from lesions of pyogenic
granuloma and lichen planus. These results point to an as yet unknown
role for C5a in the pathogenesis of skin disorders beyond its
well-defined function as a chemoattractant and activator of
leukocytes.
This article has been cited by other articles:
![]() |
I. J. Laudes, J. C. Chu, M. Huber-Lang, R.-F. Guo, N. C. Riedemann, J. V. Sarma, F. Mahdi, H. S. Murphy, C. Speyer, K. T. Lu, et al. Expression and Function of C5a Receptor in Mouse Microvascular Endothelial Cells J. Immunol., November 15, 2002; 169(10): 5962 - 5970. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. C. Riedemann, R.-F. Guo, V. J. Sarma, I. J. Laudes, M. Huber-Lang, R. L. Warner, E. A. Albrecht, C. L. Speyer, and P. A. Ward Expression and Function of the C5a Receptor in Rat Alveolar Epithelial Cells J. Immunol., February 15, 2002; 168(4): 1919 - 1925. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Drouin, J. Kildsgaard, J. Haviland, J. Zabner, H. P. Jia, P. B. McCray Jr., B. F. Tack, and R. A. Wetsel Expression of the Complement Anaphylatoxin C3a and C5a Receptors on Bronchial Epithelial and Smooth Muscle Cells in Models of Sepsis and Asthma J. Immunol., February 1, 2001; 166(3): 2025 - 2032. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. L. Schieferdecker, G. Schlaf, M. Koleva, O. Gotze, and K. Jungermann Induction of Functional Anaphylatoxin C5a Receptors on Hepatocytes by In Vivo Treatment of Rats with IL-6 J. Immunol., May 15, 2000; 164(10): 5453 - 5458. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |